Pulse Biosciences, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $1.2M | $28.6M | $2.8M |
| Jun 2017 | $3.8M | $27.9M | $2.0M |
| Sep 2017 | $4.2M | $54.1M | $32.4M |
| Dec 2017 | $3.8M | $49.8M | $3.4M |
| Mar 2018 | $3.7M | $44.8M | $10.7M |
| Jun 2018 | $4.5M | $39.5M | $6.8M |
| Sep 2018 | $4.7M | $32.7M | $6.3M |
| Dec 2018 | $4.3M | $70.6M | $51.1M |
| Mar 2019 | $4.3M | $63.5M | $8.5M |
| Jun 2019 | $7.2M | $57.0M | $10.8M |
| Sep 2019 | $7.7M | $48.7M | $9.6M |
| Dec 2019 | $11.2M | $41.9M | $6.9M |
| Mar 2020 | $10.1M | $31.8M | $7.9M |
| Jun 2020 | $16.1M | $58.4M | $37.8M |
| Sep 2020 | $17.0M | $49.7M | $7.1M |
| Dec 2020 | $18.4M | $41.3M | $12.5M |
| Mar 2021 | $60.2M | $80.6M | $59.9M |
| Jun 2021 | $20.3M | $80.0M | $47.4M |
| Sep 2021 | $19.8M | $67.1M | $42.0M |
| Dec 2021 | $14.8M | $59.2M | $44.4M |
| Mar 2022 | $18.7M | $39.5M | $12.7M |
| Jun 2022 | $17.2M | $40.6M | $14.8M |
| Sep 2022 | $81.4M | $87.6M | $69.2M |
| Dec 2022 | $80.1M | $77.9M | $61.1M |
| Mar 2023 | $80.9M | $70.2M | $54.1M |
| Jun 2023 | $14.3M | $74.8M | $58.7M |
| Sep 2023 | $13.8M | $65.9M | $50.4M |
| Dec 2023 | $14.8M | $59.2M | $44.4M |
| Mar 2024 | $12.9M | $49.2M | $34.9M |
| Jun 2024 | $13.5M | $40.4M | $26.2M |
| Sep 2024 | $13.9M | $93.0M | $79.0M |
| Dec 2024 | $17.6M | $132.5M | $118.0M |
| Mar 2025 | $14.9M | $133.4M | $119.3M |
| Jun 2025 | $15.8M | $120.3M | $106.3M |
| Sep 2025 | $16.1M | $108.8M | $95.2M |
| Dec 2025 | $13.9M | $94.5M | $80.7M |
| Mar 2026 | $15.3M | $81.6M | $68.3M |
| Jun 2026 | $16.1M | $115.6M | $101.6M |